Novartis (RNAI Research and Development Portfolio) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Novartis (RNAI Research and Development Portfolio) General Information

Description

Provider of research and development services to the pharmaceutical industry. The company's services include computer modeling and simulation, clinical development, clinical trials and drug discovery for disorders ranging from cancer to degenerative diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Arrowhead Pharmaceuticals
Primary Office
  • Lichtstrasse 35
  • 4056 Basel
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (RNAI Research and Development Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (RNAI Research and Development Portfolio)‘s full profile, request access.

Request a free trial

Novartis (RNAI Research and Development Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (RNAI Research and Development Portfolio)‘s full profile, request access.

Request a free trial